Stocks

$32 Million Financing Round Fuels N-Power Medicine's Oncology Research Expansion

Guavy AI Editorial Team Published September 1, 2026

Instruments

MRK

N-Power Medicine, an oncology drug development platform, has secured $32 million in Series B financing to expand its community oncology clinical research network and adopt its Prospective External Control Arms (ProECA) technology. The funding round features Labcorp Venture Fund as a new strategic…

The Wire

Read the full article for free.

A free account opens the rest of this article, how it scored, and the full Wire stream. No card required.

Create free account Already have an account? Sign in

No spam. Unsubscribe anytime.

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

Terms Privacy Policy